Osimertinib

Osimertinib is a targeted cancer medication used primarily to treat certain types of non-small cell lung cancer that have specific genetic mutations in the EGFR gene. It works by blocking signals that promote cancer cell growth and survival, helping to slow or stop the spread of the disease. Osimertinib is often prescribed when other treatments are no longer effective or if the cancer has developed resistance. It is usually taken orally and requires supervision by a healthcare provider to monitor for side effects and effectiveness.